Urenco

Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.

Record order book providing strong underpinning for Urenco's growing capital investment programme.

Urenco is an international supplier of enrichment services and fuel cycle products for the civil nuclear industry, serving utility customers worldwide who provide low carbon electricity through nuclear generation.

Our purpose, vision, mission and values drive our strategic objectives and determine the culture of our organisation.

Our Board manages overall control of the organisation’s affairs and is responsible to the shareholders for key policies and strategic direction.

Watch the first two chapters of our corporate film, which explain the role nuclear energy plays in meeting the demands of modern day living and the stages that make up the nuclear fuel cycle.

We have an essential role in enabling the generation of reliable, low carbon electricity for consumers worldwide.

We are the only company in the world to operate enrichment facilities in four countries.

We supply uranium enrichment services and fuel cycle products to more than 50 customers in 20+ countries.

We have business arms dedicated to advanced fuels, isotopes and nuclear stewardship.

We provide safe, cost-effective and reliable uranium enrichment services and fuel cycle products for power generation within a framework of high environmental, social responsibility and corporate governance standards.

Our customers typically supply us with natural uranium, uranium hexafluoride, which we then enrich to international specifications, using centrifuge technology designed and deployed by Urenco. Through the flexible operation of this technology, we are also able to provide products and services beyond enrichment; for example, by conserving natural uranium and providing enriched uranium product.

We also use our technical expertise to serve the wider nuclear industry. We are actively pursuing a strategy to produce advanced nuclear fuels, such as high assay low enriched uranium (HALEU) and low enriched uranium plus (LEU+). We have subsidiaries dedicated to responsible nuclear stewardship and we produce stable isotope products with medical, industrial and research applications.

We are unique in the global enrichment market in having four enrichment facilities in four different countries. These are located in Germany ( Urenco Deutschland ), the Netherlands ( Urenco Nederland ), the UK ( Urenco UK ) and the USA ( UUSA ). Our Head Office is located in London in the UK and we have a marketing office in Arlington in the USA.

We are committed to leading the way in responsible uranium stewardship and have several subsidiaries dedicated to overseeing our work in this area. Urenco ChemPlants operates our Tails Management Facility in the UK, which deconverts the by-product of enrichment into a more stable form for long term storage for future enrichment or final disposal, and Urenco Nuclear Stewardship , also based in the UK, is responsible for the management of nuclear materials, decommissioning and recycling.

Our Isotopes business ( Urenco Isotopes ) in the Netherlands draws on our expertise and capabilities in centrifuge technology to produce a variety of stable isotopes for medical, industrial and research applications.

Our Advanced Fuels Facility in the UK is expected to start producing HALEU nuclear fuel by the early 2030s, which will support next-generation reactors and reinforce the UK nuclear fuel supply chain.

We also own a 50% interest in Enrichment Technology Company (ETC), a joint venture company with Orano. ETC provides enrichment plant design services and gas centrifuge technology for enrichment plants through its subsidiaries in France, Germany, the Netherlands and the UK.